Inventor

John M. Maraganore

Inventor
Tewksbury, MA, US

Overview

21→
Patents
1991–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides21%
C12NMicroorganisms or enzymes16%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11%
C12YEnzymes2%
PatentTitleYear
11,118,181Compositions and methods for inhibition of expression of protein C (PROC) genes202110,501,740Compositions and methods for inhibiting expression of factor V201910,273,478Compositions and methods for inhibition of expression of protein C (PROC) genes20199,725,718'Compositions and methods for inhibition of expression of protein C (PROC) genes'20179,441,225'Compositions and methods for inhibiting expression of factor V'20169,068,184'Compositions and methods for inhibition of expression of protein C (PROC) genes'20158,658,782'Compositions and methods for inhibiting expression of factor V'20145,691,311'Methods for coating invasive devices with inhibitors of thrombin'19975,545,615'A method of inhibiting fertilization by alpha-1-antitrypsin or antithrombin III'19965,514,409'Methods for coating invasive devices with inhibitors of thrombin'19965,446,131'Thrombin receptor antagonists'19955,433,940'Inhibitors of thrombin'19955,425,936'Inhibitors of thrombin'19955,256,559'Methods and compositions for inhibiting platelet aggregation'19935,242,810'Bifunctional inhibitors of thrombin and platelet activation'19935,240,913'Inhibitors of thrombin'19935,196,403'Method of inhibiting platelet activation'19935,196,404'Inhibitors of thrombin'19935,182,260'DNA sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them'19935,149,528'Cytotoxic protein from Trichosanthes kirilowii'19924,985,541'Novel cytotoxic protein'1991

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1991–1996Patents assigned to ZYMOGENETICS INC (3)· patent assignee history
1991–1996Based in Waltham, MA, US· patent location history
1993–1997Patents assigned to BIOGEN INC (11)· patent assignee history
1993Patents assigned to UNIV BOSTON (3)· patent assignee history
1993–1995Based in Tewksbury, MA, US· patent location history
1993–1997Based in Concord, MA, US· patent location history
2014–2015Patents assigned to MARAGANORE JOHN M (2)· patent assignee history
2014–2019Based in Charlestown, MA, US· patent location history
2015–2021Patents assigned to ALNYLAM PHARMACEUTICALS INC (6)· patent assignee history
2017–2021Based in Charleston, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOGEN INC111993–1997
ALNYLAM PHARMACEUTICALS INC62015–2021
UNIV BOSTON31993
ZYMOGENETICS INC31991–1996
MARAGANORE JOHN Mself22014–2015
Locations
LocationPatentsSpan
Tewksbury, Massachusetts, US61993–1995
Concord, Massachusetts, US51993–1997
Charleston, Massachusetts, US32017–2021
Charlestown, Massachusetts, US32014–2019
Waltham, Massachusetts, US31991–1996